Does molluscum keep him away from his friends?

Not representative of all patients

Calendar Icon

When left untreated, symptoms last an average of 13 months and can last for as long as 4 years.1-3

Many dermatologists believe that early treatment of molluscum may1,2,4,5:

  • Reduce disease progression
  • Control the number of lesions and decrease the potential for scarring
  • Avoid the spread to other areas of the body or to other people
  • Prevent onset and exacerbation of comorbidities such as atopic dermatitis
  • Reduce discomfort and itching
  • Prevent social exclusion from school or extracurricular activities
  • Alleviate anxiety in children and caregivers
  • Improve quality of life for patients
Video Icon

View the mechanism of disease for molluscum contagiosum:

Once introduced into the epithelium, molluscum causes infected cells to rapidly proliferate and form lesions on the surface of the skin.6

Video Icon

Hear from dermatologists about the benefits of treating this highly contagious condition early.

Molluscum is a common, persistent skin infection affecting children throughout the United States. There are medical reasons for treatment, and families may prefer interventional therapy over watching and waiting for symptoms to subside.1

Form Icon

Stay informed about this condition through communications from Verrica Pharmaceuticals.

Limit 250 characters.
*Denotes a required field.

References: 1. Silverberg NB. Pediatric molluscum: an update. Cutis. 2019;104(5):301-305. Accessed January 7, 2021. https://www.mdedge.com/dermatology/article/211564/pediatrics/pediatric-molluscum-update 2. American Academy of Pediatrics. Molluscum contagiosum. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2018:565-566. https://redbook.solutions.aap.org/redbook.aspx 3. Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infect Dis. 2015;15(2):190-195. doi:10.1016/S1473-3099(14)71053-9 4. van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum (review). Cochrane Database Syst Rev. 2017;5(5):CD004767. doi:10.1002/14651858.CD004767.pub4 5. Silverberg NB. Pediatric molluscum contagiosum: optimal treatment strategies. Pediatr Drugs. 2003;5(8):505-512. doi:10.2165/00148581-200305080-00001 6. Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect Dis. 2013;13(10):877-888. doi:10.1016/S1473-3099(13) 70109-9

© 2021 Verrica Pharmaceuticals. All rights reserved. COMM90.01